Lindsay C Thompson
Overview
Explore the profile of Lindsay C Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cevik M, Thompson L, Upton C, Rolla V, Malahleha M, Mmbaga B, et al.
Lancet Infect Dis
. 2024 May;
24(9):1003-1014.
PMID: 38768617
Background: The current tuberculosis (TB) drug development pipeline is being re-populated with candidates, including nitroimidazoles such as pretomanid, that exhibit a potential to shorten TB therapy by exerting a bactericidal...
2.
Arenas-Pinto A, Judd A, Melvin D, Le Prevost M, Foster C, Sturgeon K, et al.
PLoS One
. 2022 Sep;
17(9):e0273645.
PMID: 36107958
Learning and memory are important for successful education and career progression. We assess these functions in young people (YP) with perinatal HIV (PHIV) (with or without a previous AIDS-defining illness)...
3.
Judd A, Melvin D, Thompson L, Foster C, Le Prevost M, Evangeli M, et al.
J Assoc Nurses AIDS Care
. 2020 May;
31(5):574-586.
PMID: 32467489
Young people living with perinatally acquired HIV may be at risk of poor adherence to antiretroviral therapy; identification of predictors, using a conceptual framework approach proposed previously by others, is...
4.
Copelyn J, Thompson L, Le Prevost M, Castro H, Sturgeon K, Rowson K, et al.
BMC Public Health
. 2019 Aug;
19(1):1165.
PMID: 31455290
Background: Self-harm in adolescents is of growing concern internationally but limited evidence exists on the prevalence of self-harm in those living with HIV, who may be at higher risk of...
5.
Judd A, Foster C, Thompson L, Sturgeon K, Le Prevost M, Jungmann E, et al.
PLoS One
. 2018 Oct;
13(10):e0205597.
PMID: 30312343
As adolescents with perinatal HIV (PHIV) survive into adulthood, gaining insight into sexual behaviour and risk-taking is important. Between 2013-2015, 296 PHIV aged 13-21 years and 96 HIV negative affected...
6.
Collins V, Ichimura K, Di Y, Pearson D, Chan R, Thompson L, et al.
Acta Neuropathol Commun
. 2014 Jun;
2:68.
PMID: 24952577
We evaluated the prognostic and predictive value of a range of molecular changes in the setting of a randomised trial comparing standard PCV (procarbazine, CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) and vincristine) chemotherapy with...
7.
Chambers P, Daniels S, Thompson L, Stephens R
J Clin Oncol
. 2012 Sep;
30(31):3897-8.
PMID: 22965968
No abstract available.
8.
Vale C, Thompson L, Murphy C, Forcat S, Hanley B
Trials
. 2012 Jan;
13:9.
PMID: 22243649
Background: We aimed to establish levels of consumer involvement in randomised controlled trials (RCTs), meta-analyses and other studies carried out by the UK Medical Research Council (MRC) Clinical Trials Unit...
9.
Seymour M, Thompson L, Wasan H, Middleton G, Brewster A, Shepherd S, et al.
Lancet
. 2011 May;
377(9779):1749-59.
PMID: 21570111
Background: Elderly and frail patients with cancer, although often treated with chemotherapy, are under-represented in clinical trials. We designed FOCUS2 to investigate reduced-dose chemotherapy options and to seek objective predictors...
10.
Brada M, Stenning S, Gabe R, Thompson L, Levy D, Rampling R, et al.
J Clin Oncol
. 2010 Sep;
28(30):4601-8.
PMID: 20855843
Purpose: Temozolomide (TMZ) is an alkylating agent licensed for treatment of high-grade glioma (HGG). No prospective comparison with nitrosourea-based chemotherapy exists. We report, to our knowledge, the first randomized trial...